Portfolio Overview

The Medical Technology Stock Letter currently covers the companies listed below. The majority of our portfolio have been long-term investments; MTSL consistently adds new independent recommendations (e.g., MDGL and ESPR were new ideas in 2016 and 2017, respectively). Click on the company name for general information about the company, our CEO insight, a link to the company pipeline and government registry and results database on completed, ongoing and planned clinical trials.

Portfolio company updates are our analysis of key recent and upcoming near-term events and catalysts specific to each company, accompanied by our BUY LIMIT and TARGET PRICE. In-depth coverage and complete updates of the companies in our portfolio are available only to MTSL subscribers.*


 

Ticker

Company

Updates

ACAD Acadia Get latest update
TCRT** Alaunos Therapeutics Get latest update
ALKS Alkermes Get latest update
BCYC Bicycle Therapeutics Get latest update
BMRN BioMarin Get latest update
CLDX Celldex Get latest update
ESPR Esperion Get latest update
INCY Incyte Get latest update
IONS Ionis Get latest update
MDGL Madrigal Get latest update
MYOV Myovant Get latest update
PCRX Pacira Get latest update
PLXP PLx Pharma Get latest update
PGEN Precigen Get latest update
SGMO Sangamo Get latest update
SKYE Skye Bioscience Get latest update
THRN Thorne Get latest update
VXRT Vaxart Get latest update
VKNG viking Get latest update

*Disclaimer
**ZIOP changed name to Alaunos Therapeutics (TCRT) in Feb. 2022